EE43 Health Care Resource Utilization (HCRU) and Costs of First-Line Systemic Therapy (1LT) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (a/mNSCLC) - A Secondary Analysis of Claims Data from the United States (US)
Abstract
Authors
A.I. Spira S. Knoll T.W. Smith A. Scotchmer M. Bauer